Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies
- PMID: 8378093
Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies
Abstract
We have previously reported the identification of a novel putative proto-oncogene involved in the breakpoint of a t(10;14)(q24;q32) chromosomal translocation in a case of B-cell lymphoma. This gene, called lyt-10 (NFKB2/p52), is a member of the NF-kappa B family of transcription factors and displays a high degree of homology with the NFKB1/p50. Here we describe the genomic organization of the lyt-10 gene based on the restriction analysis of genomic phage clones and the sequence determination of exon-intron boundaries. The lyt-10 gene spans a genomic region of about 8 kb on 10q24, and contains 24 exons, ranging in size between 41 and 258 base pairs. To improve the understanding of the role of lyt-10 in lymphomagenesis, we performed Southern blot analysis to detect alterations of the lyt-10 gene in a large panel of cases representative of different types of lymphoid malignancies. We found rearrangements in 5 of 228 (approximately 2%) cases analysed: two cases of B-cell lymphoma, one case of multiple myeloma and two cases of T-cell lymphoma. The use of various probes specific for different regions of the lyt-10 locus revealed that rearrangements in positive cases lead to the partial or total deletion of the carboxy-terminal region containing the ankyrin domain. Taken together, our results indicate that lyt-10 gene rearrangements represent a recurrent lesion that may be involved in the pathogenesis of both B- and T-cell malignancies, and suggest that truncation of the ankyrin domain may be a common mechanism of lesion leading to abnormal lyt-10 activation in lymphoid neoplasia.
Similar articles
-
Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies.Blood. 1994 Dec 1;84(11):3850-60. Blood. 1994. PMID: 7949142
-
The complete exon-intron structure of the 156-kb human gene NFKB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I kappa B-gamma: implications for NF-kappa B-mediated signal transduction.Genomics. 1995 Dec 10;30(3):493-505. doi: 10.1006/geno.1995.1270. Genomics. 1995. PMID: 8825636
-
Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.Oncogene. 1994 Mar;9(3):923-33. Oncogene. 1994. PMID: 8108136
-
The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies.Leuk Lymphoma. 1996 Sep;23(1-2):43-8. doi: 10.3109/10428199609054800. Leuk Lymphoma. 1996. PMID: 9021684 Review.
-
Immunoglobulin and T-cell receptor gene rearrangement.Hematol Oncol Clin North Am. 1994 Aug;8(4):751-70. Hematol Oncol Clin North Am. 1994. PMID: 7961289 Review.
Cited by
-
NF-κB2 mutation targets survival, proliferation and differentiation pathways in the pathogenesis of plasma cell tumors.BMC Cancer. 2012 May 29;12:203. doi: 10.1186/1471-2407-12-203. BMC Cancer. 2012. PMID: 22642622 Free PMC article.
-
New insights into the role of nuclear factor-kappaB in cell growth regulation.Am J Pathol. 2001 Aug;159(2):387-97. doi: 10.1016/s0002-9440(10)61708-7. Am J Pathol. 2001. PMID: 11485895 Free PMC article. Review.
-
Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.EMBO J. 2006 Oct 18;25(20):4820-32. doi: 10.1038/sj.emboj.7601343. Epub 2006 Sep 21. EMBO J. 2006. PMID: 16990795 Free PMC article.
-
Nuclear factor-kappaB: its role in health and disease.J Mol Med (Berl). 2004 Jul;82(7):434-48. doi: 10.1007/s00109-004-0555-y. Epub 2004 Jun 3. J Mol Med (Berl). 2004. PMID: 15175863 Review.
-
Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture.J Exp Med. 1998 Jan 19;187(2):147-59. doi: 10.1084/jem.187.2.147. J Exp Med. 1998. PMID: 9432973 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous